slide_0slide_1slide_2slide_3slide_4

Preparing for your first visit

http://www.beaujolais-challenge.com/?nikolsa=rencontre-femme-algerien&1ab=48 We understand that the anticipation of your first visit can be filled with anxiety. You are about to meet a team of medical professionals dedicated to your recovery.

Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized

05/22/18

http://ajm-web-designs.co.uk/cxor/richmond-3596.php The 2018 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline and cancer incidence dropped in men and remained stable in women. A companion study reports on recent changes in prostate … Read More


The Pendulum Swings (Back) on Prostate Cancer Screening

05/08/18

enter By David Sampson The U.S. Preventive Services Task Force (USPSTF) has updated its guideline for prostate cancer screening. The group now recommends that men ages 55 to 69 who are interested in screening talk to their doctors about potential benefits … Read More


U.S. Preventive Services Task Force Supports Informed Decision making for Prostate Cancer Screening

05/08/18

espace rencontre charleroi rue du presbytere By David Sampson The U.S. Preventive Services Task Force (USPSTF) has updated its recommendations for prostate cancer screening, now recommending that men 55 to 69 who are interested in screening talk to their doctors about potential benefits and harms of … Read More


NCI study revises molecular classification for most common type of lymphoma

04/11/18

enter In a study in The New England Journal of Medicine, NCI researchers identified genetic subtypes of diffuse large B-cell lymphoma (DLBCL), the most common type of lymphoma, that could help explain why some patients with the disease respond to treatment … Read More


NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas

03/28/18

... Guadagnare soldi online Bonus trading on line 25 Segnali opzioni binarie optionweb opzioni binarie vietate in francia Migliori azioni Interim results from a clinical trial for patients with desmoid tumors or aggressive fibromatosis (DT/DF) show that the drug sorafenib tosylate (Nexavar) extended progression-free survival compared with a placebo. …read more Source:: Cancer


Highly Processed Foods & Cancer Risk

02/15/18

By David Sampson A study out Wednesday suggests eating a lot of highly processed foods might be associated with higher rates of cancer. The study appears in BMJ, and the authors admit more study is needed, but warn that the … Read More


Rodents and Radiation: What to Take Away from New Study Findings

02/02/18

By David Sampson Preliminary data was released today from two rodent studies by the National Toxicology Program (NTP), to explore potential links between cell phones and cancer. The studies have found high exposure to radiofrequency radiation (RFR) resulted in tumors … Read More


Detecting cancer with a blood test: New study shows promise, but caution remains

01/19/18

By David Sampson A study published this week in Science reports promising results of a blood test designed to detect eight common cancer types by measuring circulating proteins and mutations in cell-free DNA. The study comes from the Johns Hopkins … Read More


Study links inflammation-causing foods to higher risk of colorectal cancer

01/18/18

By David Sampson A study in today’s JAMA Oncology links diets that include foods that can cause inflammation to an increased risk of colorectal cancer. Those foods include meats, refined grains, and high-calorie beverages. We asked Marji McCullough, SCD, RD, … Read More


Norman Sharpless sworn in as director of the National Cancer Institute

10/18/17

Norman E. a�?Neda�? Sharpless, M.D., becomes the 15th director of the National Cancer Institute (NCI). He comes to NCI from the University of North Carolina School of Medicine, where he was director of the Lineberger Comprehensive Cancer Center. …read more … Read More


6827 W Tropicana Ave.

Las Vegas, NV 89103

2340 E. Calvada Blvd, Suite #7.

Pahrump, NV 89048

Welcome to Hope Cancer Care of Nevada.

As you begin the journey toward recovery, whether you are a patient or caregiver, it is important to select a team of professionals who aim to not only treat the condition, but the entire individual as well.

At Hope Cancer Care of Nevada, we view our patients as family. Our practice utilizes state-of-the-art cancer treatment technologies including chemo within a relaxed and inviting environment; proficient cancer care doctor’s and is administered by a staff that places the patient’s dignity and comfort at the forefront.

Caregiver support, alternative practices, chemotherapy, tranquil settings and high-end modern amenities come together to create a truly comprehensive cancer care facility at our cancer center in Las Vegas, Nevada. This is the Hope difference. Take a moment to explore the possibilities available at Hope.